ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease

Elias, Pierre; Poterucha, Timothy J.; Rajaram, Vijay; Moller, Luca Matos; Rodriguez, Victor; Bhave, Shreyas; Hahn, Rebecca T.; Tison, Geoffrey; Abreau, Sean A.; Barrios, Joshua; Torres, Jessica Nicole; Hughes, J. Weston; Perez, Marco, V; Finer, Joshua; Kodali, Susheel; Khalique, Omar; Hamid, Nadira; Schwartz, Allan; Homma, Shunichi; Kumaraiah, Deepa; Cohen, David J.; Maurer, Mathew S.; Einstein, Andrew J.; Nazif, Tamim; Leon, Martin B.; Perotte, Adler J.*
Journal of the American College of Cardiology2022-8-9DOI: 10.1016/j.jacc.2022.05.029
52被引4阅读
引用收藏
分享

摘要

BACKGROUND Valvular heart disease is an important contributor to cardiovascular morbidity and mortality and re-mains underdiagnosed. Deep learning analysis of electrocardiography (ECG) may be useful in detecting aortic stenosis (AS), aortic regurgitation (AR), and mitral regurgitation (MR). OBJECTIVES This study aimed to develop ECG deep learning algorithms to identify moderate or severe AS, AR, and MR alone and in combination. METHODS A total of 77,163 patients undergoing ECG within 1 year before echocardiography from 2005-2021 were identified and split into train (n = 43,165), validation (n = 12,950), and test sets (n = 21,048; 7.8% with any of AS, AR, or MR). Model performance was assessed using area under the receiver-operating characteristic (AU-ROC) and precision -recall curves. Outside validation was conducted on an independent data set. Test accuracy was modeled using different disease prevalence levels to simulate screening efficacy using the deep learning model. RESULTS The deep learning algorithm model accuracy was as follows: AS (AU-ROC: 0.88), AR (AU-ROC: 0.77), MR (AU -ROC: 0.83), and any of AS, AR, or MR (AU-ROC: 0.84; sensitivity 78%, specificity 73%) with similar accuracy in external validation. In screening program modeling, test characteristics were dependent on underlying prevalence and selected sensitivity levels. At a prevalence of 7.8%, the positive and negative predictive values were 20% and 97.6%, respectively. CONCLUSIONS Deep learning analysis of the ECG can accurately detect AS, AR, and MR in this multicenter cohort and may serve as the basis for the development of a valvular heart disease screening program.

学科与关键词

关键词
aortic regurgitationaortic stenosisartificial intelligencedeep learningmitral regurgitationvalvular heart disease
相关
加载中…
  • Deep learning model to detect significant aortic regurgitation using electrocardiography
    Sawano, Shinnosuke; Kodera, Satoshi*; Katsushika, Susumu; Nakamoto, Mitsuhiko; Ninomiya, Kota; Shinohara, Hiroki; Higashikuni, Yasutomi; Nakanishi, Koki; Nakao, Tomoko; Seki, Tomohisa; Takeda, Norifumi; Fujiu, Katsuhito; Daimon, Masao; Akazawa, Hiroshi; Morita, Hiroyuki; Komuro, IsseiJournal of Cardiology, 2022, 79(3): 334-341.被引 17
  • Development and Validation of Deep-Learning Algorithm for Electrocardiography-Based Heart Failure Identification
    Kwon, Joon-myoung; Kim, Kyung-Hee*; Jeon, Ki-Hyun; Kim, Hyue Mee; Kim, Min Jeong; Lim, Sung-Min; Song, Pil Sang; Park, Jinsik; Choi, Rak Kyeong; Oh, Byung-HeeKorean Circulation Journal, 2019, 49(7): 629-639.被引 69
  • Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population level
    Kalmady, Sunil Vasu; Salimi, Amir; Sun, Weijie; Sepehrvand, Nariman; Nademi, Yousef; Bainey, Kevin; Ezekowitz, Justin; Hindle, Abram; Mcalister, Finlay; Greiner, Russel; Sandhu, Roopinder; Kaul, Padma*npj Digital Medicine, 2024, 7(1): 133.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of the American College of Cardiology
发表日期
2022-08-09
卷期
第 80 卷, 第 6 期
页码
613-626
DOI
10.1016/j.jacc.2022.05.029
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Institutes of Health [2T32HL007854-21]; National Institutes of Health/National Heart, Lung, and Blood Institute Award [R01HL148248]; Pfizer; Eidos Therapeutics; Google; Edwards LifeSciences; Amyloidosis Foundation; Glorney-Raisbeck Fellowship Award from the New York Academy of Medicine; Abbott Structural; Boston Scientific; Gore and Associates; General Electric; Janssen Pharmaceuticals; Myokardia; Medtronic; Abbott Vascular; JenaValve; Attralus; Canon Medical Systems; GE Healthcare; Roche Medical Systems; W. L. Gore and Associates; XyloCor Therapeutics; Abbott; Edwards; National Heart Lung and Blood Institute [T32HL007854] Funding Source: NIH RePORTER

作者

  • E

    Elias, Pierre (第一作者)

  • P

    Poterucha, Timothy J.

查看全部 26 位作者收起作者
  • R

    Rajaram, Vijay

  • M

    Moller, Luca Matos

  • R

    Rodriguez, Victor

  • B

    Bhave, Shreyas

  • H

    Hahn, Rebecca T.

  • T

    Tison, Geoffrey

  • A

    Abreau, Sean A.

  • B

    Barrios, Joshua

  • T

    Torres, Jessica Nicole

  • H

    Hughes, J. Weston

  • P

    Perez, Marco, V

  • F

    Finer, Joshua

  • K

    Kodali, Susheel

  • K

    Khalique, Omar

  • H

    Hamid, Nadira

  • S

    Schwartz, Allan

  • H

    Homma, Shunichi

  • K

    Kumaraiah, Deepa

  • C

    Cohen, David J.

  • M

    Maurer, Mathew S.

  • E

    Einstein, Andrew J.

  • N

    Nazif, Tamim

  • L

    Leon, Martin B.

  • P

    Perotte, Adler J. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417